Abstract

BackgroundPreterm infants may be more vulnerable to fractures due to physiological, metabolic and environmental factors, but an increased risk of fractures up to the age of 2 is unproven. The...

Highlights

  • Asthma and Sickle Cell Disease (SCD) both trigger airway inflammation, and the interplay of these two conditions when present together, as well as their relationship with acute chest syndrome (ACS), have been a matter of increasing scientific interest

  • The marked reduction of antibiotic use led to shorter average initial hospital stay and this was important in the post-SRC group for mothers who were without their birthing partner due to the Covid-19 visiting restrictions

  • Children with SCD and asthma have increased morbidity when compared to non-asthmatic SCD children, including higher incidence of ACS and vaso-occlusive crisis

Read more

Summary

Introduction

Asthma and Sickle Cell Disease (SCD) both trigger airway inflammation, and the interplay of these two conditions when present together, as well as their relationship with acute chest syndrome (ACS), have been a matter of increasing scientific interest. The diagnosis of child abuse is one of exclusion and otherwise unexplained fractures in infants and young children may be erroneously attributed to premature birth despite the lack of evidence. The dilemma is complicated by reports that preterm children are more likely to be subjected to abuse as compared to term children. Epidemiological and clinical data comparing fractures in both preterm and term children could help experts form an opinion on the possibility of child abuse. Neonatal hyperbilirubinemia is one of the most common presentations requiring medical attention in the 1st week of life. It is a common indication for re-admission to hospital after early discharge of newborn babies. There is no ‘standard’ accepted modality for providing phototherapy and a variety of strategies have been followed by different researchers

Objectives
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.